TrianglePUBLICATIONS · 19770373
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Nov 1
- First author
- Arndt CA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Arndt CA
- type
- Author
- name
- Stoner JA
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Hayes-Jordan AA
- type
- Author
- name
- Paidas CN
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Teot LA
- type
- Author
- name
- Wharam MD
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Anderson JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Arndt CA
- type
- Author
- name
- Stoner JA
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Hayes-Jordan AA
- type
- Author
- name
- Paidas CN
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Teot LA
- type
- Author
- name
- Wharam MD
- type
- Author
- name
- Breneman JC
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Anderson JR
- type
- Author
- bibliography ids
- nci-bib-1b8a668f721542144bd54fb4
- book metadata
- content sha256
- dbd885e27174e83cf31aecc6b57b19a3aa36b23ab5c3311f50d673f6daa6b808
- document type
- citation
- dois
- 10.1200/JCO.2009.22.3768
- electronic publication date
- display
- 2009 Sep 21
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19770373
- immutable id
- pubmed:19770373@dbd885e27174e83cf31aecc6b57b19a3aa36b23ab5c3311f50d673f6daa6b808
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 5182-8
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19770373
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- c5dc0042bfba29b0db116e4d6d984db65f8395dc0bcf820742431054b15c2572
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Nov 1
- precision
- day
- year
- 2009
- publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Preserved source evidence · Not medical advice